Abstract:Chemokines are chemotactic cytokines that promote cancer growth, metastasis, and regulate resistance to chemotherapy. Stromal cell-derived factor 1 (SDF1) also known as C-X-C motif chemokine 12 (CXCL12), a prognostic factor, is an extracellular homeostatic chemokine that is the natural ligand for chemokine receptors C-X-C chemokine receptor type 4 (CXCR4), also known as fusin or cluster of differentiation 184 (CD184) and chemokine receptor type 7 (CXCR7). CXCR4 is the most widely expressed rhodopsin-like G protein coupled chemokine receptor (GPCR). The CXCL12–CXCR4 axis is involved in tumor growth, invasion, angiogenesis, and metastasis in colorectal cancer (CRC). CXCR7, recently termed as atypical chemokine receptor 3 (ACKR3), is amongst the G protein coupled cell surface receptor family that is also commonly expressed in a large variety of cancer cells. CXCR7, like CXCR4, regulates immunity, angiogenesis, stem cell trafficking, cell growth and organ-specific metastases. CXCR4 and CXCR7 are expressed individually or together, depending on the tumor type. When expressed together, CXCR4 and CXCR7 can form homo- or hetero-dimers. Homo- and hetero-dimerization of CXCL12 and its receptors CXCR4 and CXCR7 alter their signaling activity. Only few drugs have been approved for clinical use targeting CXCL12-CXCR4/CXCR7 axis. Several CXCR4 inhibitors are in clinical trials for solid tumor treatment with limited success whereas CXCR7-specific inhibitors are still in preclinical studies for CRC. This review focuses on current knowledge of chemokine CXCL12 and its receptors CXCR4 and CXCR7, with emphasis on targeting the CXCL12–CXCR4/CXCR7 axis as a treatment strategy for CRC.

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

The role of CXCL12 in tumor microenvironment

The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment

CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies

The Role of CXCR3 and Its Ligands in Cancer

The chemokine receptors CXCR4 and CXCR7 in cancer

The CXCL12 (SDF-1)/CXCR4 Chemokine Axis: Oncogenic Properties, Molecular Targeting, and Synthetic and Natural Product CXCR4 Inhibitors for Cancer Therapy.

CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks

The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment

Regulative Role of the CXCL13-CXCR5 Axis in the Tumor Microenvironment

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases

CXCR7 in tumorigenesis and progression.

The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

Roles of CXCL12/CXCR4 axis in tumor growth and metastasis and related mechanisms

Roles of CCL2-CCR2 Axis in the Tumor Microenvironment

Potential Roles and Targeted Therapy of the CXCLs/CXCR2 Axis in Cancer and Inflammatory Diseases

Drug Design Targeting the Cxcr4/Cxcr7/Cxcl12 Pathway

A review on CXCR4/CXCL12 axis in oncology: No place to hide